Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/25
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 02/22/23
End: 08/30/24
Due: 08/30/25
Phase: N/A
Priority: Normal
Start: 11/15/21
End: 01/31/22
Due: 01/31/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections | NCT05750589 | iRenix Medical, Inc. | user2@example.com | None | 2025-12-31 | 2027-12-31 | 2028-12-31 | - | - | 2025-07-14 |
| SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF) | NCT05747430 | iRenix Medical, Inc. | user2@example.com | None | 2023-02-22 | 2024-08-30 | 2025-08-30 | - | - | 2025-07-14 |
| EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN) | NCT05127525 | iRenix Medical, Inc. | user2@example.com | None | 2021-11-15 | 2022-01-31 | 2023-01-31 | - | - | 2025-07-14 |